関連する実験動画
Updated: Jan 7, 2026

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
Published on: October 19, 2021
CHD2関連発達遅延モデルにおける行動およびてんかん表現型
Anat Mavashov1,2, Shaked Turk1,2, Yael Sarusi3,4
1Department of Human Molecular Genetics and Biochemistry, Gray Faculty of Medical & Health Sciences, Goldschleger Eye Research Institute, Tel Aviv University, Tel Aviv, Israel.
Objective:
Heterozygous loss-of-function mutations in the CHD2 gene, encoding chromodomain helicase DNA-binding protein 2, are associated with severe childhood onset epilepsy, global developmental delay, and autistic features. Animal models that accurately recapitulate human phenotypes are crucial for understanding rare neurodevelopmental disorders and developing novel treatments. However, such a model for CHD2-related disorders has been missing.
Methods:
We performed behavioral, electrographic, epileptic, and transcriptomic analyses to characterize a mouse model harboring a frameshift truncating mutation in the Chd2 gene (Chd2WT/m and Chd2m/m mice) on the 129X1/SvJ background.
Results:
The genetic background altered the severity of disease-related phenotypes, such that crossing the mice from the C57BL/6J onto the 129X1/SvJ background uncovered neurodevelopmental phenotypes. On the 129X1/SvJ background, Chd2m/m mice exhibited growth retardation, and both Chd2WT/m and Chd2m/m mice showed motor deficits, including clasping behavior and impaired balance on a rotating rod. Autistic like features included reduced nest-building abilities in Chd2m/m mice, whereas increased repetitive like behavior in the marble-burying test and altered social behavior were observed in Chd2WT/m mice. Electrocorticographic analysis revealed a global reduction in the power of background oscillations in both Chd2WT/m and Chd2m/m mice, along with increased susceptibility to 4-aminopyridine-induced seizures. Transcriptomic analysis identified upregulation of Kcnj11 mRNA in Chd2WT/m and Chd2m/m mice on the 129X1/SvJ background.
Significance:
This mouse model recapitulates key phenotypes observed in CHD2 patients, providing a valuable platform to study the molecular basis and potential treatment strategies for this intractable disorder.

